GLP-1 Drugs and Liver Complications; Tracking Endoscopists' Eyes; Peppermint for IBS

(MedPage Today) — GLP-1 receptor agonists and SGLT2 inhibitors were associated with lower risks for liver-related events and hepatocellular carcinoma (HCC) in type 2 diabetes patients compared with other glucose-lowering therapies, a systematic…